TSX News -
Sprott Announces 2020 First Quarter Results
TORONTO, May 08, 2020 (GLOBE NEWSWIRE) — Sprott Inc. (TSX: SII) (“Sprott” or the “Company”) today announced its financial results […]
Harsco Corporation Reports First Quarter 2020 Results
Q1 GAAP Operating Income of $3 Million Adjusted EBITDA Totaled $57 Million; Above Prior Guidance Due to Strong Performance in Clean […]
A. H. Belo Corporation Announces Filing of Its 2019 Form 10-K and Schedules Investor Call
DALLAS, May 08, 2020 (GLOBE NEWSWIRE) — A. H. Belo Corporation (NYSE: AHC) announced today that its annual report on Form […]
FibroGen to Present at Bank of America Securities 2020 Health Care Conference
SAN FRANCISCO, May 08, 2020 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) will participate in the Bank of America Securities […]
Broadwind Announces First Quarter 2020 Results
CICERO, Ill., May 08, 2020 (GLOBE NEWSWIRE) — Broadwind (NASDAQ: BWEN), a diversified precision manufacturer of specialized components and solutions […]
Apellis Pharmaceuticals to Present at the BofA Securities 2020 Health Care Conference
WALTHAM, Mass., May 08, 2020 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) a global biopharmaceutical company pioneering targeted C3 therapies, […]
EVO Reports First Quarter 2020 Results
ATLANTA, May 08, 2020 (GLOBE NEWSWIRE) — EVO Payments, Inc. (NASDAQ: EVOP) (“EVO” or the “Company”) today announced its first […]
Akoustis Announces Third 5G Network Infrastructure Filter Product and Ships Samples to Tier-1 Customer
– New 5G Band n77 XBAW™ Filter for Small Cell Base Station Applications –– Expands Product Portfolio to Thirteen XBAW […]
TG Therapeutics Strengthens Executive Team with the Addition of Owen A. O’Connor, MD, PhD, as Chief Scientific Officer
NEW YORK, May 08, 2020 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Owen A. O’Connor, MD, […]
Altimmune to Announce First Quarter 2020 Financial Results on May 14
GAITHERSBURG, Md., May 08, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it […]
